No-reflow phenomenon in cardiac MRI: Diagnosis and clinical implications

American Journal of Roentgenology

Volumn 191, Issue 1, 2008, Pages 73-79

  Pineda, Víctor ^a   Merino, Xavier ^a   Gispert, Susana ^a   Mahía, Patricia ^a   Garcia, Bruno ^a   Domínguez Oronoz, Rosa ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Cardiovascular imaging; Delayed contrast enhancement; MRI

Indexed keywords

ABCIXIMAB; FREE RADICAL; GADOLINIUM; NICORANDIL; VERAPAMIL;

ACUTE HEART INFARCTION; CONTRAST ENHANCEMENT; FIBRINOLYTIC THERAPY; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RECANALIZATION; REPERFUSION INJURY; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; CONTRAST MEDIA; CORONARY STENOSIS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NO-REFLOW PHENOMENON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 46849088596     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.2518     Document Type: Review

References (22)

1. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341:1949-1956
2. [No authors listed]. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. TIMI Study Group. N Engl J Med 1985; 312:932-936
3. Cain BS, Meldrum DR, Meng X, Shames BD, Banerjee A, Harken AH. Calcium preconditioning in human myocardium. Ann Thorac Surg 1998; 65:1065-1070
4. Reffelmann T, Kloner RA. The "no-reflow" phenomenon: basic science and clinical correlates. Heart 2002; 87:162-168
5. Kloner RA. No reflow revisited. J Am Coll Cardiol 1989; 14:1814-1815
6. Judd RM, Lugo-Olivieri CH, Arai M, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995; 92:1902-1910
7. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94:3318-3326
8. Albert TS, Kim RJ, Judd RM. Assessment of noreflow regions using cardiac MRI. Basic Res Cardiol 2006; 101:383-390
9. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003; 5:505-514
10. Thomson LE, Kim RJ, Judd RM. Magnetic resonance imaging for the assessment of myocardial viability. J Magn Reson Imaging 2004; 19:771-788
11. Lund GK, Stork A, Saeed M, et al. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology 2004; 232:49-57
12. Galiuto L, Lombardo A, Maseri A, et al. Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation. Heart 2003; 89:731-737
13. Schofer J, Montz R, Mathey DG. Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 1985; 5:593-598
14. Porter TR, Li S, Oster R, Deligonul U. The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of thrombolysis in myocardial infarction (TIMI) 3 flow in patients with acute myocardial infarction. Am J Cardiol 1998; 82:1173-1177
15. Maes A, Van de Werf F, Nuyts J, Bormans G, Desmet W, Mortelmans L. Impaired myocardial tissue perfusion early after successful thrombolysis: impact on myocardial flow, metabolism, and function at late follow-up. Circulation 1995; 92:2072-2078
16. Raff GL, O'Neill WW, Gentry RE, et al. Microvascular obstruction and myocardial function after acute myocardial infarction: assessment by using contrast-enhanced cine MR imaging. Radiology 2006; 240:529-536
17. Kenner MD, Zajac EJ, Kondos GT, et al. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol 1995; 76:861-868
18. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996; 93:223-228
19. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97:765-772
20. Rogers WJ Jr, Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999; 99:744-750
21. Gerber BL, Rochitte CE, Melin JA, et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000; 101:2734-2741
22. Neumann FJ, Blasini R, Schmitt C, et al. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 1998; 98:2695-2701